Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   (Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds
  2. Stolbov, Leonid A; Druzhilovskiy, Dmitry S; Filimonov, Dmitry A; Nicklaus,Marc; Poroikov, Vladimir V
  3. Molecules (Basel, Switzerland). 2020, Jan 1; 25(1):
  1. 2.   Why Are Some Driver Mutations Rare?
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. Trends in pharmacological sciences. 2019, Dec; 40(12): 919-929.
  1. 3.   Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
  2. O'Brien,Sean; Swanstrom,Adrienne; Pegu, Amarendra; Ko, Sung-Youl; Immonen,Taina; Del Prete,Greg; Fennessey,Christine; Gorman, Jason; Foulds, Kathryn E.; Schmidt, Stephen D.; Doria-Rose, Nicole; Williamson, Carolyn; Hatziioannou, Theodora; Bieniasz, Paul D.; Li, Hui; Shaw, George M.; Mascola, John R.; Koup, Richard A.; Kwong, Peter D.; Lifson,Jeffrey; Roederer, Mario; Keele,Brandon
  3. PLoS pathogens. 2019, APR; 15(4): e1007632.
  1. 4.   How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors
  2. Pogodin, Pavel V; Lagunin, Alexey A; Rudik, Anastasia V; Filimonov, Dmitry A; Druzhilovskiy, Dmitry S; Nicklaus, Marc; Poroikov, Vladimir V
  3. Frontiers in chemistry. 2018, Apr 26; 6: 133.
  1. 5.   Chemoinformatics at the CADD Group of the National Cancer Institute
  2. Peach,Megan; Nicklaus,Marc
  3. Applied Chemoinformatics: Achievements and Future Opportunities. 2018; 385-393.
  1. 6.   A study in scarlet-convalescent plasma for severe influenza
  2. Beigel, J. H.; Luke, T. C.
  3. Critical Care Medicine. 2012, Mar; 40(3): 1027-1028.
  1. 7.   Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
  2. Burton, D. R.; Hessell, A. J.; Keele, B. F.; Klasse, P. J.; Ketas, T. A.; Moldt, B.; Dunlop, D. C.; Poignard, P.; Doyle, L. A.; Cavacini, L.; Veazey, R. S.; Moore, J. P.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(27): 11181-11186.
  1. 8.   Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1
  2. Zhang, M. Y.; Borges, A. R.; Ptak, R. G.; Wang, Y. P.; Dimitrov, A. S.; Alam, S. M.; Wieczorek, L.; Bouma, P.; Fouts, T.; Jiang, S. B.; Polonis, V. R.; Haynes, B. F.; Quinnan, G. V.; Montefiori, D. C.; Dimitrov, D. S.
  3. Mabs. 2010, May-Jun; 2(3): 266-274.
  1. 9.   Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization
  2. Herrmann, J. E.; Wang, S. X.; Zhang, C. Y.; Panchal, R. G.; Bavari, S.; Lyons, C. R.; Lovchik, J. A.; Golding, B.; Shiloach, J.; Lu, S.
  3. Vaccine. 2006, Jul; 24(31-32): 5872-5880.
  1. 10.   Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners
  2. Nallamsetty, S.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, JAN; 45(1): 175-182.
  1. 11.   Endogenous leukemia inhibitory factor attenuates endotoxin response
  2. Weber, M. A.; Schnyder-Candrian, S.; Schnyder, B.; Quesniaux, V.; Poli, V.; Stewart, C. L.; Ryffel, B.
  3. Laboratory Investigation. 2005, FEB; 85(2): 276-284.
  1. 12.   Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
  2. Willey, R. L.; Byrum, R.; Piatak, M.; Kim, Y. B.; Cho, M. W.; Rossio, J. L.; Bess, J.; Igarashi, T.; Endo, Y.; Arthur, L. O.; Lifson, J. D.; Martin, M. A.
  3. Journal of Virology. 2003 77(2): 1163-1174.
  1. 13.   Evaluating Nanomedicines: Obstacles and Advancements
  2. Swierczewska, Magdalena; Crist, Rachael; McNeil, Scott
  3. Methods in molecular biology (Clifton, N.J.). 2018 1682: 3-16.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel